 |
|
AstraZeneca, the British pharmaceutical company, has initiated a global withdrawal of its COVID-19 vaccine, Covishield. This move comes after reports that the vaccine can cause rare side effects, including blood clots and a low blood platelet count. The company has stated that the withdrawal is due to commercial reasons, as there is now a surplus of updated vaccines available that are more effective against new variants of the virus.
The withdrawal of Covishield is a significant development in the fight against the COVID-19 pandemic. The vaccine has been used in over 100 countries, and has been credited with saving millions of lives. However, the emergence of new variants has made it less effective, and updated vaccines are now available that provide better protection against these variants.
The withdrawal of Covishield is a reminder that the COVID-19 pandemic is still evolving. New variants of the virus are constantly emerging, and vaccines must be updated to remain effective. The pharmaceutical industry is working hard to develop new vaccines that are more effective against these variants, and it is likely that we will see more vaccine withdrawals in the future as new and improved vaccines become available.
Source: AstraZeneca Withdraws Covid Vaccine Globally, Cites Commercial Reasons: Report